•  
  •  
  •  
  •  

2025-12-23 10:48:29

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  NykaaFashion

Stock Report

  • Starting October 19, Foot Locker is set to make its India debut
  • Mish Designs Limited finds a New Home at Nykaa Fashion - A Perfect Blend of Style and Elegance
  • Foot Locker announces strategic partnership with Metro Brands Ltd and Nykaa Fashion
  • Nykaa Fashion announces Janhvi Kapoor as its brand ambassador
  • Nykaa Fashion brings Revolve to India
  • Nykaa Fashion expands into men's innerwear and athleisure category with GLOOT
  • Nykaa Fashion launches LIKHA - A new Indian ethnic offering for everyday style
  • It's time to upgrade your accessory drip as Nykaa Fashion Launches IYKYK
  • RSVP by Nykaa Fashion collaborates with designer Nikhil Thampi
  • Nykaa Fashion Launches NA-KO, One of Europe's Fastest-Growing Fashion Brands, in India

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024